Doctors say medicines supply chain vulnerabilities impact patient care and must be strengthened. Shortages and erosion of trust in the supply chain seen             during the COVID-19 pandemic call for solutions. 

Survey data show healthcare practitioner perspectives on the need to make the medicines supply chain more resilient to prepare for future public health crises.

  • 95% of physicians surveyed believe COVID-19 revealed vulnerabilities in the medicines supply chain that are not going away.

  • 90% are concerned that the global medicines supply chain may not be reliable in a time of crisis. 

  • 83% believe drug shortages have become a bigger problem in recent years.

  • 73% feel their trust in the ability of the supply chain to deliver safe, quality medicines has eroded.

  • A large majority believe responsibility for keeping the supply chain resilient spans sectors and countries.


Learn more about how we are working to strengthen the global supply of medicines.

Sign up below to download the full results of USP's physician survey on the state of the medicines supply chain and the impact of COVID-19.

By providing your contact information to USP, and pressing the Submit Request button, you consent to receive news and/or promotional alerts via email from USP. You may opt out at any time by following the instructions included in every email alert sent to you by USP. You further agree to terms of USP’s Privacy Policy.